Kintara Therapeutics Inc (KTRA)
0.184
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
0.1756
-0.01
(-4.57%)
After-Hours: 20:00
Kintara Therapeutics Enterprise Value: 14.08M for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 14.08M |
| May 21, 2024 | 13.91M |
| May 20, 2024 | 13.58M |
| May 17, 2024 | 11.81M |
| May 16, 2024 | 11.93M |
| May 15, 2024 | 11.15M |
| May 14, 2024 | 10.98M |
| May 13, 2024 | 11.53M |
| May 10, 2024 | 12.16M |
| May 09, 2024 | 12.51M |
| May 08, 2024 | 12.12M |
| May 07, 2024 | 12.40M |
| May 06, 2024 | 11.92M |
| May 03, 2024 | 12.27M |
| May 02, 2024 | 12.59M |
| May 01, 2024 | 12.09M |
| April 30, 2024 | 12.49M |
| April 29, 2024 | 12.89M |
| April 26, 2024 | 12.13M |
| April 25, 2024 | 12.64M |
| April 24, 2024 | 11.49M |
| April 23, 2024 | 11.24M |
| April 22, 2024 | 10.22M |
| April 19, 2024 | 10.62M |
| April 18, 2024 | 9.796M |
| Date | Value |
|---|---|
| April 17, 2024 | 9.642M |
| April 16, 2024 | 9.824M |
| April 15, 2024 | 9.99M |
| April 12, 2024 | 10.82M |
| April 11, 2024 | 10.76M |
| April 10, 2024 | 11.00M |
| April 09, 2024 | 11.18M |
| April 08, 2024 | 11.34M |
| April 05, 2024 | 11.10M |
| April 04, 2024 | 11.85M |
| April 03, 2024 | 12.97M |
| April 02, 2024 | 9.454M |
| April 01, 2024 | 9.321M |
| March 28, 2024 | 13.65M |
| March 27, 2024 | 13.09M |
| March 26, 2024 | 13.10M |
| March 25, 2024 | 13.07M |
| March 22, 2024 | 13.17M |
| March 21, 2024 | 13.17M |
| March 20, 2024 | 13.11M |
| March 19, 2024 | 13.11M |
| March 18, 2024 | 13.14M |
| March 15, 2024 | 13.27M |
| March 14, 2024 | 13.51M |
| March 13, 2024 | 14.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.362M
Minimum
Oct 11 2019
89.06M
Maximum
Feb 10 2021
21.77M
Average
14.74M
Median
Aug 05 2022
Enterprise Value Benchmarks
| ARCA biopharma Inc | 11.10M |
| Shockwave Medical Inc | 12.08B |
| Vanda Pharmaceuticals Inc | -96.75M |
| Heron Therapeutics Inc | 620.71M |
| Asensus Surgical Inc | 58.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.011M |
| Total Expenses (Quarterly) | 2.085M |
| EPS Diluted (Quarterly) | -0.05 |
| Earnings Yield | -2.21K% |